Thrombosis prevention in percutaneous coronary interventions

Abstract

The introduction of drug-eluting stents has been a major achievement of interventional cardiology. These stents demonstrate good clinical effectiveness and safety profile. However, prevention of restenosis and late stent thrombosis remains an important problem. The potential of antithrombotic treatment (Aspirin, clopidogrel) and postintervention management in patients with drug-eluting and non-drug-eluting stents are discussed.

Keywords

• percutaneous coronary intervention
• antithrombotic therapy
• clopidogrel
• restenosis
• late stent thrombosis